Six cycles of adjuvant anthracycline-taxane-based chemotherapy compared with eight cycles for women with breast cancer.

被引：0
|
作者：
Lee, Michael
Wilson, Sheridan
Porter, David James
机构：
[1] BC Canc, Vancouver, BC, Canada
[2] Auckland Canc & Blood Ctr, Auckland, New Zealand
[3] Auckland City Hosp, Dept Oncol, Auckland, New Zealand
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e12045
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12045
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant anthracycline and taxane
    Okanami, Yuko
    Ito, Yoshinori
    Watanabe, Chie
    Iijima, Kotaro
    Iwase, Takuji
    Tokudome, Nahomi
    Takahashi, Shunji
    Hatake, Kiyohiko
    BREAST CANCER, 2011, 18 (03) : 182 - 188
  • [32] Predictors of Fatigue 30 Days After Completing Anthracycline Plus Taxane Adjuvant Chemotherapy for Breast Cancer
    Wielgus, Kimberly K.
    Berger, Ann M.
    Hertzog, Melody
    ONCOLOGY NURSING FORUM, 2009, 36 (01) : 38 - 48
  • [33] Metabolic study of women receiving adjuvant chemotherapy for breast cancer.
    Heimburger, DC
    Heini, AF
    Gower, BA
    Kim, R
    Ferguson, SM
    FASEB JOURNAL, 1998, 12 (04): : A567 - A567
  • [34] Four cycles of docetaxel-cyclophosphamide versus anthracycline-taxane adjuvant chemotherapy in node negative, HER2-negative breast cancer: A real-world comparison
    Hannouf, Malek Bassam
    Batra, Atul
    Lupichuka, Sasha
    CANCER RESEARCH, 2021, 81 (04)
  • [35] Course of fatigue between two cycles of adjuvant chemotherapy in breast cancer patients
    de Jong, Nynke
    Kester, Arnold D. M.
    Schouten, Harry C.
    Abu-Saad, Huda Huijer
    Courtens, Annemie M.
    CANCER NURSING, 2006, 29 (06) : 467 - 477
  • [36] First analysis of ASTER study AT for 3 cycles followed by CMF for 3 cycles as neo or adjuvant chemotherapy in early stage breast cancer. A single institution experience
    Mariani, G.
    Galli, G.
    Mariani, P.
    Bianchi, G. V.
    Capri, G.
    Cresta, S.
    Damian, S.
    De Benedictis, E.
    Valagussa, P.
    Magazzu, D.
    De Braud, F. G.
    Moliterni, A.
    CANCER RESEARCH, 2013, 73
  • [37] Impact of the addition of carboplatin to anthracycline-taxane-based neoadjuvant chemotherapy on survival inBRCA1/2-mutated triple-negative breast cancer
    Zhang, Juan
    Yao, Lu
    Liu, Yiqiang
    Ouyang, Tao
    Li, Jinfeng
    Wang, Tianfeng
    Fan, Zhaoqing
    Fan, Tie
    Lin, Benyao
    Xie, Yuntao
    INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (04) : 941 - 949
  • [38] Taxane and Anthracycline Based Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer : Institutional Experience
    Gogia, Ajay
    Raina, Vinod
    Deo, Suryanarayan Vishnu
    Shukla, Nootan Kumar
    Mohanti, Bidhu Kalyan
    Sharma, Daya Nand
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (05) : 1989 - 1992
  • [39] Breast Cancer Molecular Subtypes Predict Response to Anthracycline/Taxane-Based Chemotherapy
    Parker, J. S.
    Prat, A.
    Cheang, M. C. U.
    Lenburg, M. E.
    Paik, S.
    Perou, C. M.
    CANCER RESEARCH, 2009, 69 (24) : 598S - 598S
  • [40] Exercise training during anthracycline-based chemotherapy for breast cancer.
    Fraser, Steve
    Bigaran, Ashley
    Selig, Steve
    LaGerche, Andre
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345